C152H183N49O21 — CID 157185362
8-[(2R)-2-(4,5-dihydrotetrazolo[1,5-a]quinolin-7-yl)propyl]-2-(4-methyl-5-oxo-2H-furan-3-yl)-2-azaspiro[4.5]decan-1-one;2-(4-methyl-5-oxo-2H-furan-3-yl)-8-[[(1S)-1-[5-(tetrazol-1-yl)pyrazin-2-yl]ethyl]amino]-2-azaspiro[4.5]decan-1-one;(3R)-3-methyl-2-(5-oxo-2H-furan-3-yl)-8-[[5-(tetrazol-1-yl)pyrazin-2-yl]methylamino]-2-azaspiro[4.5]decan-1-one;2-(4-methyl-5-oxo-2H-furan-3-yl)-8-[(2S)-2-[5-(tetrazol-1-yl)pyrazin-2-yl]propyl]-2-azaspiro[4.5]decan-1-one;bis((3R)-3-methyl-2-(5-oxo-2H-furan-3-yl)-8-[[6-(tetrazol-1-yl)-3-pyridinyl]methylamino]-2-azaspiro[4.5]decan-1-one);(3S)-3-methyl-2-(5-oxo-2H-furan-3-yl)-8-[[6-(tetrazol-1-yl)-3-pyridinyl]methylamino]-2-azaspiro[4.5]decan-1-one (PubChem CID 157185362) has the molecular formula C152H183N49O21 and a molecular weight of 3032.46 g/mol. Its IUPAC name is 8-[(2R)-2-(4,5-dihydrotetrazolo[1,5-a]quinolin-7-yl)propyl]-2-(4-methyl-5-oxo-2H-furan-3-yl)-2-azaspiro[4.5]decan-1-one;2-(4-methyl-5-oxo-2H-furan-3-yl)-8-[[(1S)-1-[5-(tetrazol-1-yl)pyrazin-2-yl]ethyl]amino]-2-azaspiro[4.5]decan-1-one;(3R)-3-methyl-2-(5-oxo-2H-furan-3-yl)-8-[[5-(tetrazol-1-yl)pyrazin-2-yl]methylamino]-2-azaspiro[4.5]decan-1-one;2-(4-methyl-5-oxo-2H-furan-3-yl)-8-[(2S)-2-[5-(tetrazol-1-yl)pyrazin-2-yl]propyl]-2-azaspiro[4.5]decan-1-one;bis((3R)-3-methyl-2-(5-oxo-2H-furan-3-yl)-8-[[6-(tetrazol-1-yl)-3-pyridinyl]methylamino]-2-azaspiro[4.5]decan-1-one);(3S)-3-methyl-2-(5-oxo-2H-furan-3-yl)-8-[[6-(tetrazol-1-yl)-3-pyridinyl]methylamino]-2-azaspiro[4.5]decan-1-one.
| Compound Name | 8-[(2R)-2-(4,5-dihydrotetrazolo[1,5-a]quinolin-7-yl)propyl]-2-(4-methyl-5-oxo-2H-furan-3-yl)-2-azaspiro[4.5]decan-1-one;2-(4-methyl-5-oxo-2H-furan-3-yl)-8-[[(1S)-1-[5-(tetrazol-1-yl)pyrazin-2-yl]ethyl]amino]-2-azaspiro[4.5]decan-1-one;(3R)-3-methyl-2-(5-oxo-2H-furan-3-yl)-8-[[5-(tetrazol-1-yl)pyrazin-2-yl]methylamino]-2-azaspiro[4.5]decan-1-one;2-(4-methyl-5-oxo-2H-furan-3-yl)-8-[(2S)-2-[5-(tetrazol-1-yl)pyrazin-2-yl]propyl]-2-azaspiro[4.5]decan-1-one;bis((3R)-3-methyl-2-(5-oxo-2H-furan-3-yl)-8-[[6-(tetrazol-1-yl)-3-pyridinyl]methylamino]-2-azaspiro[4.5]decan-1-one);(3S)-3-methyl-2-(5-oxo-2H-furan-3-yl)-8-[[6-(tetrazol-1-yl)-3-pyridinyl]methylamino]-2-azaspiro[4.5]decan-1-one |
|---|---|
| PubChem CID | 157185362 |
| Molecular Formula | C152H183N49O21 |
| Molecular Weight | 3032.46 g/mol |
| Exact Mass | 3030.48 |
| IUPAC Name | 8-[(2R)-2-(4,5-dihydrotetrazolo[1,5-a]quinolin-7-yl)propyl]-2-(4-methyl-5-oxo-2H-furan-3-yl)-2-azaspiro[4.5]decan-1-one;2-(4-methyl-5-oxo-2H-furan-3-yl)-8-[[(1S)-1-[5-(tetrazol-1-yl)pyrazin-2-yl]ethyl]amino]-2-azaspiro[4.5]decan-1-one;(3R)-3-methyl-2-(5-oxo-2H-furan-3-yl)-8-[[5-(tetrazol-1-yl)pyrazin-2-yl]methylamino]-2-azaspiro[4.5]decan-1-one;2-(4-methyl-5-oxo-2H-furan-3-yl)-8-[(2S)-2-[5-(tetrazol-1-yl)pyrazin-2-yl]propyl]-2-azaspiro[4.5]decan-1-one;bis((3R)-3-methyl-2-(5-oxo-2H-furan-3-yl)-8-[[6-(tetrazol-1-yl)-3-pyridinyl]methylamino]-2-azaspiro[4.5]decan-1-one);(3S)-3-methyl-2-(5-oxo-2H-furan-3-yl)-8-[[6-(tetrazol-1-yl)-3-pyridinyl]methylamino]-2-azaspiro[4.5]decan-1-one |
| SMILES | CC1=C(N2CCC3(CCC(C[C@@H](C)c4ccc5c(c4)CCc4nnnn4-5)CC3)C2=O)COC1=O.CC1=C(N2CCC3(CCC(C[C@H](C)c4cnc(-n5cnnn5)cn4)CC3)C2=O)COC1=O.CC1=C(N2CCC3(CCC(N[C@@H](C)c4cnc(-n5cnnn5)cn4)CC3)C2=O)COC1=O.C[C@@H]1CC2(CCC(NCc3ccc(-n4cnnn4)nc3)CC2)C(=O)N1C1=CC(=O)OC1.C[C@@H]1CC2(CCC(NCc3ccc(-n4cnnn4)nc3)CC2)C(=O)N1C1=CC(=O)OC1.C[C@@H]1CC2(CCC(NCc3cnc(-n4cnnn4)cn3)CC2)C(=O)N1C1=CC(=O)OC1.C[C@H]1CC2(CCC(NCc3ccc(-n4cnnn4)nc3)CC2)C(=O)N1C1=CC(=O)OC1 |
| InChI | InChI=1S/C26H31N5O3.C22H27N7O3.C21H26N8O3.3C21H25N7O3.C20H24N8O3/c1-16(19-3-5-21-20(14-19)4-6-23-27-28-29-31(21)23)13-18-7-9-26(10-8-18)11-12-30(25(26)33)22-15-34-24(32)17(22)2;1-14(17-10-24-19(11-23-17)29-13-25-26-27-29)9-16-3-5-22(6-4-16)7-8-28(21(22)31)18-12-32-20(30)15(18)2;1-13-17(11-32-19(13)30)28-8-7-21(20(28)31)5-3-15(4-6-21)25-14(2)16-9-23-18(10-22-16)29-12-24-26-27-29;3*1-14-9-21(20(30)28(14)17-8-19(29)31-12-17)6-4-16(5-7-21)22-10-15-2-3-18(23-11-15)27-13-24-25-26-27;1-13-7-20(19(30)28(13)16-6-18(29)31-11-16)4-2-14(3-5-20)21-8-15-9-23-17(10-22-15)27-12-24-25-26-27/h3,5,14,16,18H,4,6-13,15H2,1-2H3;10-11,13-14,16H,3-9,12H2,1-2H3;9-10,12,14-15,25H,3-8,11H2,1-2H3;3*2-3,8,11,13-14,16,22H,4-7,9-10,12H2,1H3;6,9-10,12-14,21H,2-5,7-8,11H2,1H3/t16-,18?,26?;14-,16?,22?;14-,15?,21?;3*14-,16?,21?;13-,14?,20?/m1001101/s1 |
| InChIKey | APBCHQHMXUIMAR-FFGOZHTKSA-N |
| XLogP | 10.72 |
| TPSA | 807.63 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 63 |
| Rotatable Bonds | 34 |
| Heavy Atoms | 222 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3032.46 |
| LogP ≤ 5 | 10.72 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 63 |
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'} |
|---|